Omnitrope Therapy: Enhancing Growth and Nutritional Status in Pediatric Patients
Reading Time: 2 minutesIntroduction to Omnitrope Therapy Omnitrope is a biosimilar recombinant human growth hormone (rhGH) approved by the FDA for the treatment of growth failure in children and adolescents due to various causes, including growth hormone deficiency, Turner syndrome, chronic renal insufficiency, and Prader-Willi syndrome. Its role in enhancing growth and development has been well-documented, but its impact on the nutritional status... Read more »
